| Code | 9794E | ||||||||
| MA number | EU/1/25/1917/001 | ||||||||
| Product Form: | con inf 1x2,5 ml/5 mg (liek.inj.skl.) | ||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||
| Type of procedure: | EU | ||||||||
| MAH, country: | Regeneron Ireland Designated Activity Company (DAC), Ireland | ||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||
| ATC: |
|
||||||||
| Shelf life: | 18 | ||||||||
| Container: | glass vial | ||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 23.04.2025 |
| Validity: | 23.04.2026 |
| SmPC + PL: |
European Medicines Agency's database
|
| Safety feature | Yes |
| Data update: | 06.05.2025 |
